What You Need to Know About At-Home Vaginal Microbiome Testing

Tech entrepreneur Bryan Johnson, known for spending millions on anti-aging treatments, has started testing his girlfriend's vaginal microbiome using commercial at-home kits. He shared this as part of his broader health-tracking routine.

This practice highlights a growing market for vaginal microbiome testing. Companies like Evvy, Tiny Health, Viome, and ZOE now sell these tests directly to consumers for $199 to $600 each. Johnson's decision shows how the "quantified self" movement—people tracking their own biology in detail—is now extending into reproductive health.

How the Testing Works

These at-home tests work similarly to ancestry DNA kits you may have seen advertised. You collect a sample at home and mail it to a laboratory that sequences and analyzes the bacteria living in the vagina. The labs that do this work are certified medical facilities, which means they follow strict quality standards.

Different companies use slightly different technologies to analyze the samples. Some sequence DNA directly to identify bacteria, while others look at RNA—which is like reading the instructions bacteria are currently following rather than just reading their identity cards. The differences between companies affect how precisely they can identify organisms and what insights they provide.

What Research Shows

Scientists have studied vaginal microbiomes extensively in recent years. Research published in Nature Medicine and other journals has found that the types and amounts of bacteria living in the vagina can predict certain health outcomes. For instance, some microbiome patterns have been linked to increased risk of early delivery during pregnancy.

This research is real and matters for medicine. But it has mostly looked at people during pregnancy or with specific health concerns—not healthy women being tested repeatedly.

Questions Worth Considering

The broader context here raises some issues worth thinking through. Vaginal microbiomes change naturally throughout a person's menstrual cycle, after sexual activity, and in response to many other factors. A healthy vaginal microbiome typically has lots of Lactobacillus bacteria, but what the "optimal" composition looks like for any individual person remains unclear.

Johnson's practice also touches on privacy and consent in relationships. Testing someone else's biological samples—even a partner—creates ongoing records of intimate health information. This raises real questions about who owns that data and what it means to share such detailed tracking with another person. We have seen similar concerns emerge before, when early genetic testing enthusiasts would test family members and share results without fully understanding the privacy implications.

The Gap Between Science and Consumer Testing

There is a meaningful difference between research showing that microbiome composition correlates with health outcomes and having a clear reason to test yourself or a partner regularly. The science establishes the connection. What it does not yet establish is whether frequent testing of healthy people actually helps them stay healthy or make better decisions.

Consumer microbiome testing kits are now available and more sophisticated than they were even five years ago. But the ability of companies to offer a test does not mean we yet know how to act on the results for someone without active health concerns.

As these tests become cheaper and easier to access, the Johnson case may spark broader conversations about how much of our intimate biology should be tracked and shared. The technology is real. The clinical usefulness for healthy people is still being figured out.